Verona Pharma (VRNA) Short Interest Ratio & Short Volume $66.18 -0.60 (-0.90%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$66.76 +0.58 (+0.88%) As of 03/25/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verona Pharma Short Interest DataVerona Pharma (VRNA) has a short interest of 9.00 million shares, representing 11.83% of the float (the number of shares available for trading by the public). This marks a 15.68% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.7, indicating that it would take 6.7 days of the average trading volume of 1.14 million shares to cover all short positions.Current Short Interest9,000,000 sharesPrevious Short Interest7,780,000 sharesChange Vs. Previous Month+15.68%Dollar Volume Sold Short$626.67 millionShort Interest Ratio6.7 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares80,820,000 sharesShort Percent of Float11.83%Today's Trading Volume726,334 sharesAverage Trading Volume1,141,551 sharesToday's Volume Vs. Average64% Short Selling Verona Pharma? Sign up to receive the latest short interest report for Verona Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRNA Short Interest Over TimeVRNA Days to Cover Over TimeVRNA Percentage of Float Shorted Over Time Remove Ads Verona Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/20259,000,000 shares $626.67 million +15.7%11.8%6.7 $69.63 2/15/20257,780,000 shares $499.55 million -6.2%10.2%6.1 $64.21 1/31/20258,290,000 shares $475.02 million +0.9%N/A6.9 $57.30 1/15/20258,220,000 shares $413.55 million +19.1%N/A7.1 $50.31 12/31/20246,900,000 shares $320.44 million +4.1%N/A6.3 $46.44 12/15/20246,630,000 shares $274.61 million +4.3%N/A6.6 $41.42 11/30/20246,360,000 shares $252.05 million +6.4%N/A6.2 $39.63 11/15/20245,980,000 shares $213.25 million -20.5%N/A5.8 $35.66 10/31/20247,520,000 shares $255.15 million -5.3%N/A7 $33.93 10/15/20247,940,000 shares $270.52 million -0.9%N/A7.7 $34.07 Get the Latest News and Ratings for VRNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verona Pharma and its competitors with MarketBeat's FREE daily newsletter. 9/30/20248,010,000 shares $230.45 million -9.5%N/A6.8 $28.77 9/15/20248,850,000 shares $263.55 million -1.8%N/A6.2 $29.78 8/31/20249,010,000 shares $247.59 million -15.8%N/A6 $27.48 8/15/202410,700,000 shares $291.58 million +21.0%N/A7.2 $27.25 7/31/20248,840,000 shares $200.31 million -8.2%N/A6.5 $22.66 7/15/20249,630,000 shares $207.05 million +11.5%N/A7.5 $21.50 6/30/20248,640,000 shares $124.93 million +11.9%N/A8.2 $14.46 6/15/20247,720,000 shares $116.88 million +28.7%N/A10.1 $15.14 5/31/20246,000,000 shares $72.42 million +7.7%N/A10.5 $12.07 5/15/20245,570,000 shares $77.70 million -8.8%N/A11.4 $13.95 4/30/20246,110,000 shares $94.40 million +0.7%N/A13.5 $15.45 4/15/20246,070,000 shares $95.91 million -7.5%N/A13.8 $15.80 3/31/20246,560,000 shares $105.55 million +2.5%N/A13.3 $16.09 3/15/20246,400,000 shares $100.16 million +1.0%N/A11.7 $15.65 2/29/20246,340,000 shares $109.17 million -5.2%11.5%10.8 $17.22 2/15/20246,690,000 shares $112.06 million -2.2%12.2%11.6 $16.75 1/31/20246,840,000 shares $125.51 million +0.7%N/A12.5 $18.35 1/15/20246,790,000 shares $121.81 million +4.0%N/A11.9 $17.94 12/31/20236,530,000 shares $129.82 million +4.7%N/A11.9 $19.88 12/15/20236,240,000 shares $107.76 million -4.2%N/A13.3 $17.27 11/30/20236,510,000 shares $88.02 million +3.7%N/A16.7 $13.52 11/15/20236,280,000 shares $90.12 million +4.2%N/A17.8 $14.35 10/31/20236,030,000 shares $84.12 million +53.1%N/A17.3 $13.95 10/15/20233,940,000 shares $52.84 million -14.2%N/A12.7 $13.41 9/30/20234,590,000 shares $74.82 million +4.1%N/A15.1 $16.30 9/15/20234,410,000 shares $77.66 million +14.3%N/A13.9 $17.61 8/31/20233,860,000 shares $75.00 million +1.6%N/A11.2 $19.43 8/15/20233,800,000 shares $69.05 million +8.9%N/A10.5 $18.17 7/31/20233,490,000 shares $77.09 million +3.9%N/A8.7 $22.09 7/15/20233,360,000 shares $74.22 million +0.3%N/A8.1 $22.09Elon’s Greatest Invention… Hidden in South Memphis? (Ad)Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after May 1st, it could be too late. 6/30/20233,350,000 shares $70.82 million +24.1%5.8%7 $21.14 6/15/20232,700,000 shares $57.02 million +1.9%4.7%5.3 $21.12 5/31/20232,650,000 shares $57.03 million +13.3%4.6%5.2 $21.52 5/15/20232,340,000 shares $48.95 million +2.2%4.1%4.3 $20.92 4/30/20232,290,000 shares $47.98 million +21.8%N/A4.1 $20.95 4/15/20231,880,000 shares $40.36 million +3.9%N/A3.1 $21.47 3/31/20231,810,000 shares $36.34 million +15.3%N/A3.1 $20.08 3/15/20231,570,000 shares $28.54 million +4.0%2.9%1.5 $18.18 2/28/20231,510,000 shares $32.37 million -7.4%2.8%1.4 $21.44 2/15/20231,630,000 shares $35.52 million +1.2%3.0%1.6 $21.79 1/31/20231,610,000 shares $35.48 million +7.3%3.1%1.7 $22.04 1/15/20231,500,000 shares $35.88 million +20.0%2.9%1.7 $23.92 12/30/20221,250,000 shares $32.66 million +95.0%2.4%1.5 $26.13 12/15/2022640,900 shares $8.21 million -4.7%1.2%0.9 $12.81 11/30/2022672,800 shares $8.68 million -14.5%1.3%2.8 $12.90 11/15/2022786,700 shares $9.73 million -8.0%1.5%3.3 $12.37 10/31/2022855,200 shares $10.95 million +12.3%N/A1.9 $12.80 10/15/2022761,500 shares $7.62 million +25.7%1.6%0.8 $10.01 9/30/2022605,900 shares $6.19 million -3.3%1.2%0.6 $10.22 9/15/2022626,500 shares $6.77 million +19.0%1.3%0.7 $10.80 8/31/2022526,300 shares $5.48 million -30.8%1.1%0.6 $10.42 8/15/2022760,100 shares $9.49 million +1,753.9%1.8%0.9 $12.48 7/31/202241,000 shares $220,580.00 +122.8%0.1%0.1 $5.38 7/15/202218,400 shares $100,280.00 +25.2%0.0%0.2 $5.45 6/30/202214,700 shares $61,593.00 -57.6%0.0%0.2 $4.19 6/15/202234,700 shares $160,348.70 +65.2%0.1%0.4 $4.62 5/31/202221,000 shares $95,130.00 +13.5%0.1%0.2 $4.53 5/15/202218,500 shares $69,375.00 -42.7%0.1%0.2 $3.75 4/30/202232,300 shares $135,014.00 -46.5%0.1%0.4 $4.18 4/15/202260,400 shares $245,224.00 +42.5%0.2%1 $4.06 3/31/202242,400 shares $211,576.00 -26.1%0.1%0.7 $4.99 3/15/202257,400 shares $287,000.00 -33.6%0.1%0.8 $5.00 2/28/202286,400 shares $485,568.00 +7.1%0.2%0.8 $5.62 2/15/202280,700 shares $483,393.00 -33.7%0.2%0.7 $5.99 1/31/2022121,800 shares $756,378.00 -10.2%0.3%1.1 $6.21 1/15/2022135,600 shares $915,300.00 -14.4%0.3%1.3 $6.75 12/31/2021158,400 shares $1.06 million -21.4%N/A1.7 $6.72 12/15/2021201,400 shares $920,398.00 +52.8%0.5%2.2 $4.57 11/30/2021131,800 shares $630,004.00 -0.8%0.3%1.8 $4.78 11/15/2021132,800 shares $703,840.00 -17.3%0.3%1.8 $5.30 10/29/2021160,500 shares $821,760.00 +10.3%0.4%1.8 $5.12 10/15/2021145,500 shares $736,230.00 -13.2%0.4%1.6 $5.06 9/30/2021167,700 shares $918,996.00 -10.1%0.4%1.8 $5.48 9/15/2021186,600 shares $1.01 million -28.1%0.5%2.1 $5.40 8/31/2021259,500 shares $1.51 million -10.7%0.7%3 $5.82 8/13/2021290,600 shares $1.73 million +29.2%0.7%3.8 $5.94 7/30/2021225,000 shares $1.41 million +9.0%0.6%3.1 $6.28 7/15/2021206,500 shares $1.16 million -12.6%0.5%2.8 $5.64 6/30/2021236,200 shares $1.54 million -14.8%0.6%3.3 $6.54 6/15/2021277,300 shares $1.99 million +34.9%0.7%3.6 $7.18Elon’s Greatest Invention… Hidden in South Memphis? (Ad)Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after May 1st, it could be too late. 5/28/2021205,500 shares $1.24 million +30.4%0.5%2.9 $6.05 5/14/2021157,600 shares $914,080.00 -23.6%N/A2 $5.80 4/30/2021206,300 shares $1.40 million -12.8%N/A2.1 $6.80 4/15/2021236,600 shares $1.94 million +114.9%N/A1.8 $8.20 3/31/2021110,100 shares $833,457.00 +12.2%N/A0.8 $7.57 3/15/202198,100 shares $860,337.00 +104.8%N/A0.8 $8.77 2/26/202147,900 shares $445,470.00 +82.8%N/A0.4 $9.30 2/12/202126,200 shares $230,822.00 -61.6%N/A0.2 $8.81 1/29/202168,300 shares $512,250.00 -14.9%N/A0.7 $7.50 1/15/202180,300 shares $615,098.00 +4.0%N/A1.5 $7.66 12/31/202077,200 shares $545,804.00 -14.8%N/A1.1 $7.07 12/15/202090,600 shares $731,142.00 +40.3%N/A1.3 $8.07 11/30/202064,600 shares $468,350.00 +13.3%N/A0.9 $7.25 10/30/202078,600 shares $453,522.00 -5.1%N/A0.7 $5.77 10/15/202082,800 shares $466,164.00 -43.0%N/A0.5 $5.63 9/30/2020145,200 shares $906,048.00 +65.0%N/A0.1 $6.24 9/15/202088,000 shares $609,840.00 +1,213.4%N/A0.1 $6.93 8/31/20206,700 shares $46,967.00 -89.7%N/A0 $7.01 8/14/202065,200 shares $537,900.00 -45.5%N/A0 $8.25 7/31/2020119,700 shares $816,354.00 +2,750.0%N/A0.1 $6.82 7/15/20204,200 shares $18,690.00 -74.1%0.1%0 $4.45 6/30/202016,200 shares $73,548.00 +31.7%0.2%0.3 $4.54 6/15/202012,300 shares $62,730.00 +70.8%0.1%0.2 $5.10 5/29/20207,200 shares $34,344.00 +157.1%0.1%0.1 $4.77 5/15/20202,800 shares $11,788.00 -81.1%0.0%0.1 $4.21 4/30/202014,800 shares $62,752.00 +78.3%0.2%0.3 $4.24 4/15/20208,300 shares $36,105.00 -22.4%0.1%0.1 $4.35 3/31/202010,700 shares $44,084.00 -58.5%0.1%0.1 $4.12 VRNA Short Interest - Frequently Asked Questions What is Verona Pharma's current short interest? Short interest is the volume of Verona Pharma shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 9,000,000 shares of VRNA short. 11.83% of Verona Pharma's shares are currently sold short. Learn More on Verona Pharma's current short interest. What is a good short interest ratio for Verona Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRNA shares currently have a short interest ratio of 7.0. Learn More on Verona Pharma's short interest ratio. Which institutional investors are shorting Verona Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Verona Pharma: Wolverine Trading LLC, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Verona Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.83% of Verona Pharma's floating shares are currently sold short. Is Verona Pharma's short interest increasing or decreasing? Verona Pharma saw a increase in short interest in February. As of February 28th, there was short interest totaling 9,000,000 shares, an increase of 15.7% from the previous total of 7,780,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Verona Pharma's short interest compare to its competitors? 11.83% of Verona Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Verona Pharma: Teva Pharmaceutical Industries Limited (2.47%), Summit Therapeutics Inc. (25.07%), Intra-Cellular Therapies, Inc. (2.25%), Genmab A/S (0.36%), Moderna, Inc. (13.19%), Viatris Inc. (2.30%), Dr. Reddy's Laboratories Limited (2.23%), Ascendis Pharma A/S (10.93%), Sarepta Therapeutics, Inc. (5.74%), Vaxcyte, Inc. (10.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Verona Pharma stock? Short selling VRNA is an investing strategy that aims to generate trading profit from Verona Pharma as its price is falling. VRNA shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Verona Pharma? A short squeeze for Verona Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRNA, which in turn drives the price of the stock up even further. How often is Verona Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRNA, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies TEVA Short Squeeze SMMT Short Squeeze ITCI Short Squeeze GMAB Short Squeeze MRNA Short Squeeze VTRS Short Squeeze RDY Short Squeeze ASND Short Squeeze SRPT Short Squeeze PCVX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRNA) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts